nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP2C18—malignant glioma	0.617	1	CbGaD
Omeprazole—CYP1A2—Carmustine—malignant glioma	0.0799	0.57	CbGbCtD
Omeprazole—CYP3A4—Temozolomide—malignant glioma	0.0604	0.431	CbGbCtD
Omeprazole—Dysplasia—Carmustine—malignant glioma	0.0123	0.0957	CcSEcCtD
Omeprazole—Leg edema—Temozolomide—malignant glioma	0.00368	0.0286	CcSEcCtD
Omeprazole—Tongue discolouration—Temozolomide—malignant glioma	0.00205	0.016	CcSEcCtD
Omeprazole—Lansoprazole—CYP2C18—malignant glioma	0.00175	1	CrCbGaD
Omeprazole—Visual acuity reduced—Temozolomide—malignant glioma	0.00167	0.013	CcSEcCtD
Omeprazole—Encephalopathy—Carmustine—malignant glioma	0.0016	0.0124	CcSEcCtD
Omeprazole—Cyst—Carmustine—malignant glioma	0.00153	0.0119	CcSEcCtD
Omeprazole—Parosmia—Temozolomide—malignant glioma	0.00153	0.0119	CcSEcCtD
Omeprazole—Apathy—Temozolomide—malignant glioma	0.00139	0.0108	CcSEcCtD
Omeprazole—Flat affect—Temozolomide—malignant glioma	0.00137	0.0107	CcSEcCtD
Omeprazole—Scotoma—Carmustine—malignant glioma	0.00135	0.0105	CcSEcCtD
Omeprazole—Necrosis—Carmustine—malignant glioma	0.00131	0.0102	CcSEcCtD
Omeprazole—Scotoma—Temozolomide—malignant glioma	0.0013	0.0102	CcSEcCtD
Omeprazole—Otitis media—Temozolomide—malignant glioma	0.00127	0.0099	CcSEcCtD
Omeprazole—Rigors—Temozolomide—malignant glioma	0.00121	0.00944	CcSEcCtD
Omeprazole—Petechiae—Temozolomide—malignant glioma	0.0012	0.00937	CcSEcCtD
Omeprazole—Accidental injury—Carmustine—malignant glioma	0.00116	0.00902	CcSEcCtD
Omeprazole—Leukocytosis—Carmustine—malignant glioma	0.00109	0.00849	CcSEcCtD
Omeprazole—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00109	0.00848	CcSEcCtD
Omeprazole—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00105	0.00815	CcSEcCtD
Omeprazole—Injection site reaction—Carmustine—malignant glioma	0.00102	0.00793	CcSEcCtD
Omeprazole—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000991	0.00771	CcSEcCtD
Omeprazole—Vaginal inflammation—Temozolomide—malignant glioma	0.000991	0.00771	CcSEcCtD
Omeprazole—Candida infection—Carmustine—malignant glioma	0.000979	0.00762	CcSEcCtD
Omeprazole—Candida infection—Temozolomide—malignant glioma	0.000946	0.00736	CcSEcCtD
Omeprazole—Vaginal infection—Temozolomide—malignant glioma	0.000936	0.00728	CcSEcCtD
Omeprazole—Neoplasm—Carmustine—malignant glioma	0.000927	0.00721	CcSEcCtD
Omeprazole—Gynaecomastia—Carmustine—malignant glioma	0.000917	0.00714	CcSEcCtD
Omeprazole—Dry eye—Temozolomide—malignant glioma	0.000915	0.00712	CcSEcCtD
Omeprazole—Neoplasm—Temozolomide—malignant glioma	0.000896	0.00697	CcSEcCtD
Omeprazole—Abnormal vision—Carmustine—malignant glioma	0.000894	0.00696	CcSEcCtD
Omeprazole—Abnormal vision—Temozolomide—malignant glioma	0.000864	0.00672	CcSEcCtD
Omeprazole—Swelling—Carmustine—malignant glioma	0.000844	0.00657	CcSEcCtD
Omeprazole—Ear pain—Temozolomide—malignant glioma	0.000843	0.00656	CcSEcCtD
Omeprazole—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000827	0.00643	CcSEcCtD
Omeprazole—Gastroenteritis—Temozolomide—malignant glioma	0.000812	0.00631	CcSEcCtD
Omeprazole—Injury—Carmustine—malignant glioma	0.00081	0.0063	CcSEcCtD
Omeprazole—Vascular purpura—Temozolomide—malignant glioma	0.000804	0.00626	CcSEcCtD
Omeprazole—Hepatic failure—Temozolomide—malignant glioma	0.0008	0.00623	CcSEcCtD
Omeprazole—Hot flush—Temozolomide—malignant glioma	0.000769	0.00598	CcSEcCtD
Omeprazole—Menopausal symptoms—Temozolomide—malignant glioma	0.000762	0.00593	CcSEcCtD
Omeprazole—Thirst—Temozolomide—malignant glioma	0.000756	0.00588	CcSEcCtD
Omeprazole—Hyponatraemia—Carmustine—malignant glioma	0.000747	0.00582	CcSEcCtD
Omeprazole—Purpura—Temozolomide—malignant glioma	0.000746	0.00581	CcSEcCtD
Omeprazole—Diplopia—Carmustine—malignant glioma	0.000744	0.00579	CcSEcCtD
Omeprazole—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000744	0.00579	CcSEcCtD
Omeprazole—Diplopia—Temozolomide—malignant glioma	0.000719	0.0056	CcSEcCtD
Omeprazole—Face oedema—Carmustine—malignant glioma	0.000719	0.00559	CcSEcCtD
Omeprazole—Face oedema—Temozolomide—malignant glioma	0.000694	0.0054	CcSEcCtD
Omeprazole—Hypokalaemia—Carmustine—malignant glioma	0.000677	0.00527	CcSEcCtD
Omeprazole—Dry skin—Temozolomide—malignant glioma	0.000659	0.00513	CcSEcCtD
Omeprazole—Muscular weakness—Carmustine—malignant glioma	0.000656	0.00511	CcSEcCtD
Omeprazole—Hypokalaemia—Temozolomide—malignant glioma	0.000655	0.00509	CcSEcCtD
Omeprazole—Breast disorder—Temozolomide—malignant glioma	0.00065	0.00506	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000648	0.00504	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000648	0.00504	CcSEcCtD
Omeprazole—Dysphagia—Carmustine—malignant glioma	0.000643	0.00501	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000634	0.00494	CcSEcCtD
Omeprazole—Muscular weakness—Temozolomide—malignant glioma	0.000634	0.00494	CcSEcCtD
Omeprazole—Abdominal distension—Temozolomide—malignant glioma	0.000626	0.00487	CcSEcCtD
Omeprazole—Dysphagia—Temozolomide—malignant glioma	0.000622	0.00484	CcSEcCtD
Omeprazole—Pancytopenia—Carmustine—malignant glioma	0.000611	0.00475	CcSEcCtD
Omeprazole—Sweating increased—Temozolomide—malignant glioma	0.000606	0.00471	CcSEcCtD
Omeprazole—Neutropenia—Carmustine—malignant glioma	0.000602	0.00468	CcSEcCtD
Omeprazole—Pancytopenia—Temozolomide—malignant glioma	0.00059	0.00459	CcSEcCtD
Omeprazole—Dysuria—Temozolomide—malignant glioma	0.000581	0.00452	CcSEcCtD
Omeprazole—Neutropenia—Temozolomide—malignant glioma	0.000581	0.00452	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000578	0.0045	CcSEcCtD
Omeprazole—Pollakiuria—Temozolomide—malignant glioma	0.000574	0.00447	CcSEcCtD
Omeprazole—Erectile dysfunction—Temozolomide—malignant glioma	0.000573	0.00446	CcSEcCtD
Omeprazole—Depression—Carmustine—malignant glioma	0.000572	0.00445	CcSEcCtD
Omeprazole—Photosensitivity reaction—Temozolomide—malignant glioma	0.000567	0.00442	CcSEcCtD
Omeprazole—Weight increased—Temozolomide—malignant glioma	0.000566	0.0044	CcSEcCtD
Omeprazole—Renal failure—Carmustine—malignant glioma	0.000564	0.00439	CcSEcCtD
Omeprazole—Weight decreased—Temozolomide—malignant glioma	0.000562	0.00438	CcSEcCtD
Omeprazole—Stomatitis—Carmustine—malignant glioma	0.000559	0.00435	CcSEcCtD
Omeprazole—Urinary tract infection—Carmustine—malignant glioma	0.000558	0.00434	CcSEcCtD
Omeprazole—Infestation NOS—Temozolomide—malignant glioma	0.000554	0.00431	CcSEcCtD
Omeprazole—Infestation—Temozolomide—malignant glioma	0.000554	0.00431	CcSEcCtD
Omeprazole—Depression—Temozolomide—malignant glioma	0.000553	0.0043	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00055	0.00428	CcSEcCtD
Omeprazole—Stomatitis—Temozolomide—malignant glioma	0.00054	0.0042	CcSEcCtD
Omeprazole—Urinary tract infection—Temozolomide—malignant glioma	0.000539	0.00419	CcSEcCtD
Omeprazole—Hepatobiliary disease—Temozolomide—malignant glioma	0.000524	0.00408	CcSEcCtD
Omeprazole—Sinusitis—Temozolomide—malignant glioma	0.00052	0.00405	CcSEcCtD
Omeprazole—Hypoaesthesia—Carmustine—malignant glioma	0.000512	0.00399	CcSEcCtD
Omeprazole—Hallucination—Carmustine—malignant glioma	0.000512	0.00399	CcSEcCtD
Omeprazole—Oedema peripheral—Carmustine—malignant glioma	0.000507	0.00395	CcSEcCtD
Omeprazole—Connective tissue disorder—Carmustine—malignant glioma	0.000506	0.00394	CcSEcCtD
Omeprazole—Hepatitis—Temozolomide—malignant glioma	0.000498	0.00387	CcSEcCtD
Omeprazole—Visual impairment—Carmustine—malignant glioma	0.000496	0.00386	CcSEcCtD
Omeprazole—Hypoaesthesia—Temozolomide—malignant glioma	0.000495	0.00385	CcSEcCtD
Omeprazole—Hallucination—Temozolomide—malignant glioma	0.000495	0.00385	CcSEcCtD
Omeprazole—Pharyngitis—Temozolomide—malignant glioma	0.000494	0.00384	CcSEcCtD
Omeprazole—Urinary tract disorder—Temozolomide—malignant glioma	0.000491	0.00382	CcSEcCtD
Omeprazole—Oedema peripheral—Temozolomide—malignant glioma	0.00049	0.00381	CcSEcCtD
Omeprazole—Connective tissue disorder—Temozolomide—malignant glioma	0.000489	0.0038	CcSEcCtD
Omeprazole—Urethral disorder—Temozolomide—malignant glioma	0.000488	0.0038	CcSEcCtD
Omeprazole—Eye disorder—Carmustine—malignant glioma	0.000481	0.00374	CcSEcCtD
Omeprazole—Visual impairment—Temozolomide—malignant glioma	0.00048	0.00373	CcSEcCtD
Omeprazole—Flushing—Carmustine—malignant glioma	0.000478	0.00372	CcSEcCtD
Omeprazole—Erythema multiforme—Temozolomide—malignant glioma	0.000471	0.00366	CcSEcCtD
Omeprazole—Eye disorder—Temozolomide—malignant glioma	0.000465	0.00362	CcSEcCtD
Omeprazole—Tinnitus—Temozolomide—malignant glioma	0.000464	0.00361	CcSEcCtD
Omeprazole—Flushing—Temozolomide—malignant glioma	0.000462	0.00359	CcSEcCtD
Omeprazole—Alopecia—Carmustine—malignant glioma	0.000455	0.00354	CcSEcCtD
Omeprazole—Mental disorder—Carmustine—malignant glioma	0.000451	0.00351	CcSEcCtD
Omeprazole—Immune system disorder—Temozolomide—malignant glioma	0.000449	0.0035	CcSEcCtD
Omeprazole—Mediastinal disorder—Temozolomide—malignant glioma	0.000448	0.00349	CcSEcCtD
Omeprazole—Malnutrition—Carmustine—malignant glioma	0.000448	0.00349	CcSEcCtD
Omeprazole—Chills—Temozolomide—malignant glioma	0.000447	0.00347	CcSEcCtD
Omeprazole—Alopecia—Temozolomide—malignant glioma	0.00044	0.00342	CcSEcCtD
Omeprazole—Mental disorder—Temozolomide—malignant glioma	0.000436	0.00339	CcSEcCtD
Omeprazole—Back pain—Carmustine—malignant glioma	0.000434	0.00337	CcSEcCtD
Omeprazole—Malnutrition—Temozolomide—malignant glioma	0.000433	0.00337	CcSEcCtD
Omeprazole—Dysgeusia—Temozolomide—malignant glioma	0.000424	0.0033	CcSEcCtD
Omeprazole—Vision blurred—Carmustine—malignant glioma	0.000422	0.00329	CcSEcCtD
Omeprazole—Tremor—Carmustine—malignant glioma	0.00042	0.00327	CcSEcCtD
Omeprazole—Back pain—Temozolomide—malignant glioma	0.000419	0.00326	CcSEcCtD
Omeprazole—Anaemia—Carmustine—malignant glioma	0.000414	0.00322	CcSEcCtD
Omeprazole—Agitation—Carmustine—malignant glioma	0.000412	0.00321	CcSEcCtD
Omeprazole—Vision blurred—Temozolomide—malignant glioma	0.000408	0.00318	CcSEcCtD
Omeprazole—Tremor—Temozolomide—malignant glioma	0.000406	0.00316	CcSEcCtD
Omeprazole—Ill-defined disorder—Temozolomide—malignant glioma	0.000402	0.00313	CcSEcCtD
Omeprazole—Leukopenia—Carmustine—malignant glioma	0.000401	0.00312	CcSEcCtD
Omeprazole—Anaemia—Temozolomide—malignant glioma	0.0004	0.00312	CcSEcCtD
Omeprazole—Agitation—Temozolomide—malignant glioma	0.000398	0.0031	CcSEcCtD
Omeprazole—Angioedema—Temozolomide—malignant glioma	0.000396	0.00308	CcSEcCtD
Omeprazole—Malaise—Temozolomide—malignant glioma	0.000391	0.00304	CcSEcCtD
Omeprazole—Vertigo—Temozolomide—malignant glioma	0.000389	0.00303	CcSEcCtD
Omeprazole—Leukopenia—Temozolomide—malignant glioma	0.000388	0.00302	CcSEcCtD
Omeprazole—Hypertension—Carmustine—malignant glioma	0.000387	0.00301	CcSEcCtD
Omeprazole—Palpitations—Temozolomide—malignant glioma	0.000383	0.00298	CcSEcCtD
Omeprazole—Chest pain—Carmustine—malignant glioma	0.000382	0.00297	CcSEcCtD
Omeprazole—Myalgia—Carmustine—malignant glioma	0.000382	0.00297	CcSEcCtD
Omeprazole—Anxiety—Carmustine—malignant glioma	0.00038	0.00296	CcSEcCtD
Omeprazole—Cough—Temozolomide—malignant glioma	0.000378	0.00294	CcSEcCtD
Omeprazole—Hypertension—Temozolomide—malignant glioma	0.000374	0.00291	CcSEcCtD
Omeprazole—Confusional state—Carmustine—malignant glioma	0.000369	0.00287	CcSEcCtD
Omeprazole—Myalgia—Temozolomide—malignant glioma	0.000369	0.00287	CcSEcCtD
Omeprazole—Arthralgia—Temozolomide—malignant glioma	0.000369	0.00287	CcSEcCtD
Omeprazole—Anxiety—Temozolomide—malignant glioma	0.000368	0.00286	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000366	0.00285	CcSEcCtD
Omeprazole—Discomfort—Temozolomide—malignant glioma	0.000364	0.00284	CcSEcCtD
Omeprazole—Infection—Carmustine—malignant glioma	0.000363	0.00283	CcSEcCtD
Omeprazole—Dry mouth—Temozolomide—malignant glioma	0.000361	0.00281	CcSEcCtD
Omeprazole—Thrombocytopenia—Carmustine—malignant glioma	0.000358	0.00279	CcSEcCtD
Omeprazole—Tachycardia—Carmustine—malignant glioma	0.000357	0.00278	CcSEcCtD
Omeprazole—Confusional state—Temozolomide—malignant glioma	0.000356	0.00277	CcSEcCtD
Omeprazole—Anaphylactic shock—Temozolomide—malignant glioma	0.000354	0.00275	CcSEcCtD
Omeprazole—Infection—Temozolomide—malignant glioma	0.000351	0.00273	CcSEcCtD
Omeprazole—Anorexia—Carmustine—malignant glioma	0.000349	0.00271	CcSEcCtD
Omeprazole—Nervous system disorder—Temozolomide—malignant glioma	0.000347	0.0027	CcSEcCtD
Omeprazole—Thrombocytopenia—Temozolomide—malignant glioma	0.000346	0.00269	CcSEcCtD
Omeprazole—Skin disorder—Temozolomide—malignant glioma	0.000343	0.00267	CcSEcCtD
Omeprazole—Hyperhidrosis—Temozolomide—malignant glioma	0.000342	0.00266	CcSEcCtD
Omeprazole—Anorexia—Temozolomide—malignant glioma	0.000337	0.00262	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000333	0.00259	CcSEcCtD
Omeprazole—Insomnia—Carmustine—malignant glioma	0.000331	0.00257	CcSEcCtD
Omeprazole—Paraesthesia—Carmustine—malignant glioma	0.000329	0.00256	CcSEcCtD
Omeprazole—Dyspnoea—Carmustine—malignant glioma	0.000326	0.00254	CcSEcCtD
Omeprazole—Somnolence—Carmustine—malignant glioma	0.000325	0.00253	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000322	0.00251	CcSEcCtD
Omeprazole—Insomnia—Temozolomide—malignant glioma	0.00032	0.00249	CcSEcCtD
Omeprazole—Decreased appetite—Carmustine—malignant glioma	0.000318	0.00247	CcSEcCtD
Omeprazole—Paraesthesia—Temozolomide—malignant glioma	0.000317	0.00247	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Carmustine—malignant glioma	0.000316	0.00246	CcSEcCtD
Omeprazole—Dyspnoea—Temozolomide—malignant glioma	0.000315	0.00245	CcSEcCtD
Omeprazole—Somnolence—Temozolomide—malignant glioma	0.000314	0.00245	CcSEcCtD
Omeprazole—Constipation—Carmustine—malignant glioma	0.000313	0.00243	CcSEcCtD
Omeprazole—Pain—Carmustine—malignant glioma	0.000313	0.00243	CcSEcCtD
Omeprazole—Dyspepsia—Temozolomide—malignant glioma	0.000311	0.00242	CcSEcCtD
Omeprazole—Decreased appetite—Temozolomide—malignant glioma	0.000307	0.00239	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000305	0.00237	CcSEcCtD
Omeprazole—Fatigue—Temozolomide—malignant glioma	0.000305	0.00237	CcSEcCtD
Omeprazole—Pain—Temozolomide—malignant glioma	0.000302	0.00235	CcSEcCtD
Omeprazole—Constipation—Temozolomide—malignant glioma	0.000302	0.00235	CcSEcCtD
Omeprazole—Feeling abnormal—Carmustine—malignant glioma	0.000301	0.00235	CcSEcCtD
Omeprazole—Gastrointestinal pain—Carmustine—malignant glioma	0.000299	0.00233	CcSEcCtD
Omeprazole—Feeling abnormal—Temozolomide—malignant glioma	0.000291	0.00227	CcSEcCtD
Omeprazole—Abdominal pain—Carmustine—malignant glioma	0.000289	0.00225	CcSEcCtD
Omeprazole—Body temperature increased—Carmustine—malignant glioma	0.000289	0.00225	CcSEcCtD
Omeprazole—Gastrointestinal pain—Temozolomide—malignant glioma	0.000289	0.00225	CcSEcCtD
Omeprazole—Urticaria—Temozolomide—malignant glioma	0.000281	0.00219	CcSEcCtD
Omeprazole—Abdominal pain—Temozolomide—malignant glioma	0.000279	0.00217	CcSEcCtD
Omeprazole—Body temperature increased—Temozolomide—malignant glioma	0.000279	0.00217	CcSEcCtD
Omeprazole—Hypersensitivity—Carmustine—malignant glioma	0.00027	0.0021	CcSEcCtD
Omeprazole—Asthenia—Carmustine—malignant glioma	0.000262	0.00204	CcSEcCtD
Omeprazole—Hypersensitivity—Temozolomide—malignant glioma	0.00026	0.00203	CcSEcCtD
Omeprazole—Asthenia—Temozolomide—malignant glioma	0.000254	0.00197	CcSEcCtD
Omeprazole—Diarrhoea—Carmustine—malignant glioma	0.00025	0.00195	CcSEcCtD
Omeprazole—Pruritus—Temozolomide—malignant glioma	0.00025	0.00195	CcSEcCtD
Omeprazole—Dizziness—Carmustine—malignant glioma	0.000242	0.00188	CcSEcCtD
Omeprazole—Diarrhoea—Temozolomide—malignant glioma	0.000242	0.00188	CcSEcCtD
Omeprazole—Dizziness—Temozolomide—malignant glioma	0.000234	0.00182	CcSEcCtD
Omeprazole—Vomiting—Carmustine—malignant glioma	0.000233	0.00181	CcSEcCtD
Omeprazole—Rash—Carmustine—malignant glioma	0.000231	0.00179	CcSEcCtD
Omeprazole—Dermatitis—Carmustine—malignant glioma	0.00023	0.00179	CcSEcCtD
Omeprazole—Headache—Carmustine—malignant glioma	0.000229	0.00178	CcSEcCtD
Omeprazole—Vomiting—Temozolomide—malignant glioma	0.000225	0.00175	CcSEcCtD
Omeprazole—Rash—Temozolomide—malignant glioma	0.000223	0.00173	CcSEcCtD
Omeprazole—Dermatitis—Temozolomide—malignant glioma	0.000223	0.00173	CcSEcCtD
Omeprazole—Headache—Temozolomide—malignant glioma	0.000221	0.00172	CcSEcCtD
Omeprazole—Nausea—Carmustine—malignant glioma	0.000217	0.00169	CcSEcCtD
Omeprazole—Nausea—Temozolomide—malignant glioma	0.00021	0.00163	CcSEcCtD
Omeprazole—ABCC3—Metabolism—CAV1—malignant glioma	1.45e-05	0.000129	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CAT—malignant glioma	1.42e-05	0.000127	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.42e-05	0.000126	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.39e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.39e-05	0.000124	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—IDH1—malignant glioma	1.39e-05	0.000123	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.39e-05	0.000123	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.38e-05	0.000123	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000123	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.38e-05	0.000123	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CD—malignant glioma	1.38e-05	0.000122	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—IDH1—malignant glioma	1.35e-05	0.00012	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CG—malignant glioma	1.35e-05	0.00012	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.35e-05	0.00012	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NCOR1—malignant glioma	1.34e-05	0.00012	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.34e-05	0.000119	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SPHK1—malignant glioma	1.34e-05	0.000119	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.33e-05	0.000118	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTP1—malignant glioma	1.33e-05	0.000118	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CG—malignant glioma	1.32e-05	0.000117	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.31e-05	0.000117	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SPHK1—malignant glioma	1.31e-05	0.000116	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—malignant glioma	1.31e-05	0.000116	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTT1—malignant glioma	1.3e-05	0.000116	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAT—malignant glioma	1.29e-05	0.000115	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP2C18—malignant glioma	1.28e-05	0.000114	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ASMT—malignant glioma	1.28e-05	0.000114	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—IDH1—malignant glioma	1.28e-05	0.000113	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—malignant glioma	1.27e-05	0.000113	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.27e-05	0.000112	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—IDH1—malignant glioma	1.26e-05	0.000112	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—IDH2—malignant glioma	1.26e-05	0.000112	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.24e-05	0.00011	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SPHK1—malignant glioma	1.23e-05	0.00011	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.23e-05	0.00011	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SPHK1—malignant glioma	1.22e-05	0.000109	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NCOR1—malignant glioma	1.22e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.22e-05	0.000109	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS1—malignant glioma	1.22e-05	0.000108	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.21e-05	0.000108	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.21e-05	0.000108	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCAN—malignant glioma	1.2e-05	0.000107	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.2e-05	0.000107	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CB—malignant glioma	1.2e-05	0.000107	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.19e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTT1—malignant glioma	1.19e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CD—malignant glioma	1.19e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—malignant glioma	1.19e-05	0.000106	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.19e-05	0.000105	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.18e-05	0.000105	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000103	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—BCHE—malignant glioma	1.13e-05	0.000101	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.13e-05	0.000101	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.13e-05	0.0001	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC5A5—malignant glioma	1.12e-05	9.94e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS1—malignant glioma	1.12e-05	9.93e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.11e-05	9.89e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CAV1—malignant glioma	1.1e-05	9.74e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.09e-05	9.69e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—IDH1—malignant glioma	1.08e-05	9.61e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTT1—malignant glioma	1.06e-05	9.45e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.06e-05	9.4e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.05e-05	9.32e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.05e-05	9.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SPHK1—malignant glioma	1.05e-05	9.3e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTT1—malignant glioma	1.04e-05	9.23e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BCHE—malignant glioma	1.04e-05	9.23e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CB—malignant glioma	1.04e-05	9.22e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—malignant glioma	1.04e-05	9.21e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.03e-05	9.16e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—malignant glioma	1.03e-05	9.14e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.03e-05	9.12e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.02e-05	9.11e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CB—malignant glioma	1.01e-05	8.97e-05	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.01e-05	8.96e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—malignant glioma	1e-05	8.89e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CG—malignant glioma	9.98e-06	8.87e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CAV1—malignant glioma	9.97e-06	8.86e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS1—malignant glioma	9.97e-06	8.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.94e-06	8.84e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.93e-06	8.83e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTT1—malignant glioma	9.78e-06	8.7e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS1—malignant glioma	9.73e-06	8.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—IDH2—malignant glioma	9.7e-06	8.62e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTT1—malignant glioma	9.7e-06	8.62e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.7e-06	8.62e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.66e-06	8.59e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—malignant glioma	9.63e-06	8.56e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.61e-06	8.54e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BCHE—malignant glioma	9.26e-06	8.24e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS1—malignant glioma	9.17e-06	8.15e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.15e-06	8.14e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.14e-06	8.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.12e-06	8.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS1—malignant glioma	9.09e-06	8.08e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CG—malignant glioma	9.08e-06	8.07e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.05e-06	8.05e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BCHE—malignant glioma	9.04e-06	8.04e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—malignant glioma	9.01e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—malignant glioma	8.96e-06	7.97e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC5A5—malignant glioma	8.93e-06	7.94e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.8e-06	7.82e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CD—malignant glioma	8.77e-06	7.8e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAT—malignant glioma	8.77e-06	7.79e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—malignant glioma	8.76e-06	7.79e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—malignant glioma	8.72e-06	7.75e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.65e-06	7.69e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.58e-06	7.62e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BCHE—malignant glioma	8.52e-06	7.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.49e-06	7.55e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BCHE—malignant glioma	8.45e-06	7.51e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.42e-06	7.48e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.38e-06	7.45e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.34e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—IDH1—malignant glioma	8.34e-06	7.42e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—malignant glioma	8.29e-06	7.37e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NCOR1—malignant glioma	8.28e-06	7.36e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—malignant glioma	8.26e-06	7.34e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.23e-06	7.31e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SPHK1—malignant glioma	8.07e-06	7.18e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAT—malignant glioma	8.04e-06	7.14e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CD—malignant glioma	7.98e-06	7.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2C18—malignant glioma	7.91e-06	7.03e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.89e-06	7.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.82e-06	6.95e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS1—malignant glioma	7.76e-06	6.9e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.74e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—malignant glioma	7.65e-06	6.8e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NCOR1—malignant glioma	7.59e-06	6.75e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—malignant glioma	7.58e-06	6.74e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.48e-06	6.65e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—malignant glioma	7.37e-06	6.55e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—malignant glioma	7.31e-06	6.5e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BCHE—malignant glioma	7.22e-06	6.42e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—malignant glioma	7.19e-06	6.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAT—malignant glioma	7.17e-06	6.38e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.13e-06	6.34e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAT—malignant glioma	7e-06	6.22e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—malignant glioma	6.96e-06	6.19e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—malignant glioma	6.89e-06	6.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.82e-06	6.06e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—malignant glioma	6.78e-06	6.03e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NCOR1—malignant glioma	6.77e-06	6.02e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—malignant glioma	6.75e-06	6e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.74e-06	6e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—malignant glioma	6.72e-06	5.98e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.68e-06	5.94e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NCOR1—malignant glioma	6.61e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—malignant glioma	6.61e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAT—malignant glioma	6.6e-06	5.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAT—malignant glioma	6.54e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.45e-06	5.73e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—malignant glioma	6.4e-06	5.69e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—malignant glioma	6.32e-06	5.62e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NCOR1—malignant glioma	6.23e-06	5.54e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—malignant glioma	6.19e-06	5.5e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NCOR1—malignant glioma	6.18e-06	5.49e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—malignant glioma	6.15e-06	5.47e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—malignant glioma	6.15e-06	5.46e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—malignant glioma	6.01e-06	5.35e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS1—malignant glioma	5.99e-06	5.33e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—malignant glioma	5.97e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—malignant glioma	5.93e-06	5.27e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.91e-06	5.25e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.83e-06	5.18e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—malignant glioma	5.74e-06	5.11e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.64e-06	5.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAT—malignant glioma	5.59e-06	4.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCHE—malignant glioma	5.57e-06	4.95e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—malignant glioma	5.52e-06	4.91e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.5e-06	4.89e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—malignant glioma	5.44e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—malignant glioma	5.4e-06	4.8e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—malignant glioma	5.39e-06	4.79e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOR1—malignant glioma	5.28e-06	4.69e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.28e-06	4.69e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—malignant glioma	5.17e-06	4.59e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—malignant glioma	5.08e-06	4.52e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—malignant glioma	5.04e-06	4.48e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.03e-06	4.47e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—malignant glioma	5.03e-06	4.47e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.95e-06	4.4e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—malignant glioma	4.91e-06	4.36e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—malignant glioma	4.85e-06	4.32e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.81e-06	4.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—malignant glioma	4.74e-06	4.21e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—malignant glioma	4.71e-06	4.19e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—malignant glioma	4.67e-06	4.15e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—malignant glioma	4.66e-06	4.14e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.63e-06	4.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.59e-06	4.08e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—malignant glioma	4.47e-06	3.97e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—malignant glioma	4.43e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—malignant glioma	4.43e-06	3.94e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.42e-06	3.93e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.32e-06	3.84e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—malignant glioma	4.32e-06	3.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAT—malignant glioma	4.31e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAV1—malignant glioma	4.3e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—malignant glioma	4.28e-06	3.8e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—malignant glioma	4.24e-06	3.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.11e-06	3.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOR1—malignant glioma	4.07e-06	3.62e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—malignant glioma	4.07e-06	3.62e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.07e-06	3.62e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.03e-06	3.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.92e-06	3.48e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.85e-06	3.43e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—malignant glioma	3.82e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—malignant glioma	3.81e-06	3.39e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—malignant glioma	3.78e-06	3.36e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—malignant glioma	3.76e-06	3.34e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—malignant glioma	3.73e-06	3.32e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—malignant glioma	3.73e-06	3.31e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.54e-06	3.15e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.51e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—malignant glioma	3.51e-06	3.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—malignant glioma	3.48e-06	3.1e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—malignant glioma	3.47e-06	3.08e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.45e-06	3.06e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—malignant glioma	3.33e-06	2.96e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—malignant glioma	3.32e-06	2.95e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—malignant glioma	3.25e-06	2.89e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—malignant glioma	3.06e-06	2.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—malignant glioma	3.04e-06	2.7e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.02e-06	2.69e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—malignant glioma	3e-06	2.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—malignant glioma	2.98e-06	2.65e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—malignant glioma	2.92e-06	2.6e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.87e-06	2.55e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.66e-06	2.36e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.63e-06	2.34e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—malignant glioma	2.6e-06	2.31e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.35e-06	2.09e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—malignant glioma	2.35e-06	2.09e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.32e-06	2.06e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—malignant glioma	2.3e-06	2.04e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—malignant glioma	2.29e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.16e-06	1.92e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—malignant glioma	2.15e-06	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.14e-06	1.9e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—malignant glioma	2e-06	1.78e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—malignant glioma	1.92e-06	1.71e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—malignant glioma	1.87e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.83e-06	1.63e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—malignant glioma	1.77e-06	1.57e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—malignant glioma	1.75e-06	1.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—malignant glioma	1.5e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.41e-06	1.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—malignant glioma	1.15e-06	1.03e-05	CbGpPWpGaD
